SCHEMBL9254014

SCHEMBL9254014

COC(=O)CCc1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)cc2)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 13/20 0.55
ALDH1A1 P00352 4/20 0.51
PRMT1 Q99873 2/20 0.51
HPGD P15428 2/20 0.51
TOP1 P11387 1/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
KDM4E B2RXH2 3/20 0.51
MAPT P10636 2/20 0.51
PKM P14618 2/20 0.51
TOP2A P11388 1/20 0.50
TOP2B Q02880 1/20 0.50
DDAH1 O94760 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PRSS1 P07477 2/20 0.46
TMPRSS15 P98073 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9250170 0.86 NQO2 (0.61) NQO2ALDH1A1PRMT1HPGDTOP1
SCHEMBL9254121 0.84 ALDH1A1 (0.64) NQO2ALDH1A1PRMT1HPGDTOP1
SCHEMBL9248638 0.80 RXRA (0.53) NQO2ALDH1A1PRMT1HPGDTOP1
Hydrochloric Acid SCHEMBL9254695 0.77 NQO2 (0.39) NQO2ALDH1A1HPGDKDM4EMAPT
SCHEMBL9250754 0.76 KMT2A (0.49) ALDH1A1TDP1KDM4EMAPTPKM
SCHEMBL9250757 0.75 NQO2 (0.51) NQO2HPGDPRSS1TMPRSS15
SCHEMBL17537987 0.74 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10KDM4EMAPT
SCHEMBL9258660 0.74 F2 (0.44) NQO2ALDH1A1HPGDHSD17B10KDM4E
Hydrochloric Acid SCHEMBL9254391 0.74 ST14 (0.54) PRSS1
SCHEMBL9254531 0.73 TMPRSS15 (0.43) NQO2HPGDMAPTSMN1; SMN2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed